Literature DB >> 27096166

Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.

Jessica A Kahn1, Bret J Rudy2, Jiahong Xu3, Bill Kapogiannis4, Elizabeth Secord5, Maura Gillison6.   

Abstract

Human papillomavirus (HPV), Epstein-Barr virus (EBV), and Kaposi sarcoma-associated herpes virus (KSHV) may promote oral cancers, especially among immunosuppressed individuals. The aims of this study were to examine whether demographic characteristics, medical history, sexual behaviors, substance use, CD4+ T-cell count, HIV viral load, and HPV vaccination were associated with HPV, EBV, and KSHV infection and viral load. Multivariable modeling using logistic or linear regression examined associations between independent variables and infection or viral load, respectively. Among 272 HIV-infected 12-24-year-old youth, 19.5% were positive for oral HPV, 88.2% for EBV, and 11.8% for KSHV. In multivariable models, recent marijuana use (OR 1.97, 95%CI 1.02-3.82) and lower CD4+ T-cell count (<350 vs. ≥350 cells/mm(3) : OR 1.92, 95%CI 1.003-3.69) were associated with HPV infection; lifetime tobacco use (estimated coefficient [EC] 1.55, standard error [SE] 0.53, P = 0.0052) with HPV viral load; recent tobacco use (OR 2.90, 95%CI 1.06-7.97), and higher HIV viral load (>400 vs. <400 copies/ml: OR 3.98, 95%CI 1.84-8.74) with EBV infection; Black versus White race (EC 1.18, SE 0.37, P = 0.0023), and lower CD4+ T-cell count (EC 0.70, SE 0.28, P = 0.017) with EBV viral load, male versus female gender (OR 10, 95%CI 1.32-100) with KSHV infection, and younger age at HIV diagnosis (1-14 vs. 18-20 years: EC 0.33, SE 0.16, P = 0.049; 15-17 vs. 18-20 years: EC 0.35, SE 0.13, P = 0.0099) with KSHV viral load. In conclusion, substance use and immunosuppression are associated with oral DNA tumor viruses in HIV-infected youth. J. Med. Virol. 88:1944-1952, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Epstein-Barr virus; human immunodeficiency virus; human papillomavirus; kaposi sarcoma-associated herpesvirus (human herpesvirus 8)

Mesh:

Substances:

Year:  2016        PMID: 27096166      PMCID: PMC5008985          DOI: 10.1002/jmv.24555

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  54 in total

1.  Human herpesvirus 8 oral shedding in HIV-infected men with and without Kaposi sarcoma.

Authors:  Isabelle C Widmer; Peter Erb; Heini Grob; Peter Itin; Michele Baumann; Aline Stalder; Rainer Weber; Gieri Cathomas
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-01       Impact factor: 3.731

2.  Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.

Authors:  Ru Jiang; Oleksandr Ekshyyan; Tara Moore-Medlin; Xiaohua Rong; Sean Nathan; Xin Gu; Fleurette Abreo; Eben L Rosenthal; Mingxia Shi; Joseph T Guidry; Rona S Scott; Lindsey M Hutt-Fletcher; Cherie-Ann O Nathan
Journal:  J Oral Pathol Med       Date:  2014-07-18       Impact factor: 4.253

3.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.

Authors:  A B Moscicki; N Hills; S Shiboski; K Powell; N Jay; E Hanson; S Miller; L Clayton; S Farhat; J Broering; T Darragh; J Palefsky
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

4.  Profiles of Risk Among HIV-Infected Youth in Clinic Settings.

Authors:  M Isabel Fernández; Heather C Huszti; Patrick A Wilson; Shoshana Kahana; Sharon Nichols; René Gonin; Jiahong Xu; Bill G Kapogiannis
Journal:  AIDS Behav       Date:  2015-05

5.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.

Authors:  Carole Fakhry; Gypsyamber D'souza; Elizabeth Sugar; Kathleen Weber; Eleni Goshu; Howard Minkoff; Rodney Wright; Eric Seaberg; Maura Gillison
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

7.  Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers.

Authors:  Elaine M Smith; Linda M Rubenstein; Thomas H Haugen; Eva Hamsikova; Lubomir P Turek
Journal:  Cancer Causes Control       Date:  2010-04-17       Impact factor: 2.506

Review 8.  The epidemiology of genital human papillomavirus infection.

Authors:  Helen Trottier; Eduardo L Franco
Journal:  Vaccine       Date:  2006-03-30       Impact factor: 3.641

Review 9.  Oral human papillomavirus in healthy individuals: a systematic review of the literature.

Authors:  Aimée R Kreimer; Rohini K Bhatia; Andrea L Messeguer; Paula González; Rolando Herrero; Anna R Giuliano
Journal:  Sex Transm Dis       Date:  2010-06       Impact factor: 2.830

10.  Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort.

Authors:  Carole Fakhry; Elizabeth Sugar; Gypsyamber D'Souza; Maura Gillison
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

View more
  5 in total

Review 1.  Cancer in adolescents and young adults living with HIV.

Authors:  Julia Bohlius; Caroline Foster; Gita Naidu; Mazvita Sengayi; Anna Turkova
Journal:  Curr Opin HIV AIDS       Date:  2018-05       Impact factor: 4.283

2.  Oral shedding of herpesviruses in HIV-infected patients with varying degrees of immune status.

Authors:  Dirk P Dittmer; Kristen Tamburro; Huichao Chen; Anthony Lee; Marcia K Sanders; Tischan A Wade; Sonia Napravnik; Jennifer Webster-Cyriaque; Mahmoud Ghannoum; Caroline H Shiboski; Judith A Aberg
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

Review 3.  Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review.

Authors:  Manuela Ceccarelli; Emmanuele Venanzi Rullo; Alessio Facciolà; Giordano Madeddu; Bruno Cacopardo; Rosaria Taibi; Francesco D'Aleo; Marilia Rita Pinzone; Isa Picerno; Michele di Rosa; Giuseppa Visalli; Fabrizio Condorelli; Giuseppe Nunnari; Giovanni Francesco Pellicanò
Journal:  Oncotarget       Date:  2018-03-30

Review 4.  Recent advances in cancer outcomes in HIV-positive smokers.

Authors:  Sabina Ranjit; Santosh Kumar
Journal:  F1000Res       Date:  2018-06-11

5.  Microbiomic differences at cancer-prone oral mucosa sites with marijuana usage.

Authors:  Taylor Newman; Laya P Krishnan; Jessica Lee; Guy R Adami
Journal:  Sci Rep       Date:  2019-09-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.